Jeffries have been engaged to help the company navigate the process of engaging and advising through the process of finding suitable buyers.
That is, according to The Australian last November….
The rising star in the Australian listed healthcare industry, Neuren Pharmaceuticals, is understood to have brought in a defence adviser after fielding buyer interest from US-based industry giants. DataRoom understands that Jefferies has won the mandate.
….but not according to Neuren.
Neuren appointed a corporate and strategic adviser several months ago. The appointment was a normal step in Neuren’s ongoing growth and development and not in response to any approaches from third parties. Media speculation to the contrary is unfounded.
Share Price, page-11743
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.56 |
Change
-0.360(2.59%) |
Mkt cap ! $1.733B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $6.421M | 470.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1643 | $13.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.61 | 3100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |